...
首页> 外文期刊>BMC Cancer >Intensive care unit prognostic factors in critically ill patients with advanced solid tumors: a 3-year retrospective study
【24h】

Intensive care unit prognostic factors in critically ill patients with advanced solid tumors: a 3-year retrospective study

机译:重症实体瘤重症患者的加护病房预后因素:一项为期三年的回顾性研究

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background The objective of this study was to identify risk factors predicting prognosis of critically ill medical patients with advanced solid tumors in the intensive care unit (ICU). Methods We retrospectively analyzed all ICU unplanned medical admissions to the ICU of patients with advanced solid cancer in Tianjin Medical University Cancer Institute and Hospital between October 1, 2012 and March 1, 2015. Approval was obtained from the Ethical Commission of Tianjin Medical University Cancer Institute and Hospital to review and publish information from patients’ records. Results One hundred and forty-one patients with full code status met the criteria for inclusion from among 813 ICU admissions. ICU mortality was 14.9?% and in-hospital mortality was 29.8?%. The major reasons for unplanned ICU admission were respiratory failure (38.3?%) and severe sepsis or septic shock (27.7?%). The ICU mortality in patients who required vasopressors, mechanical ventilation or renal replacement therapy for >24?h was 25, 25.9 and 40?%, respectively. The mean overall survival was 28.6?months. After adjusting for hypertension, type of solid cancer, intervention time, need for mechanical ventilation and Acute Physiology and Chronic Health Evaluation II score, only Sepsis-related Organ Failure Assessment (SOFA) score on day 7 of ICU treatment remained a significant predictor of ICU mortality (adjusted odds ratio 1.612, 95?% confidence interval 1.137–2.285, P =?0.007). Conclusions We suggest broadening the criteria for ICU admission. The patients should be allowed an ICU trial consisting of unlimited ICU support, including invasive hemodynamic monitoring, mechanical ventilation and renal replacement therapy. An interdisciplinary meeting, including an ethics consultation, should be held to make end-of-life decisions if the SOFA score on day 7 shows clinical deterioration with no available therapeutic options.
机译:背景技术这项研究的目的是在重症监护病房(ICU)中确定可预测具有晚期实体瘤的重症医学患者预后的危险因素。方法回顾性分析2012年10月1日至2015年3月1日在天津医科大学肿瘤研究所和医院就诊的所有晚期ICU患者的计划外ICU入院。获得天津医科大学肿瘤研究所伦理委员会的批准和医院查看并发布患者记录中的信息。结果813名ICU入院者中有141名完全规范状态的患者符合纳入标准。 ICU死亡率为14.9%,医院内死亡率为29.8%。计划外加重ICU的主要原因是呼吸衰竭(38.3%)和严重的败血症或败血性休克(27.7%)。需要血管加压药,机械通气或肾脏替代治疗> 24?h的患者的ICU死亡率分别为25%,25.9%和40%。平均总生存期为28.6个月。在对高血压,实体癌类型,干预时间,对机械通气的需要以及急性生理学和慢性健康评估II评分进行调整后,仅ICU治疗第7天的败血症相关器官衰竭评估(SOFA)评分仍是ICU的重要预测指标死亡率(调整后的优势比1.612,95%置信区间1.137-2.285,P = 0.007)。结论我们建议扩大ICU入院标准。应该允许患者进行ICU试验,该试验包括无限的ICU支持,包括有创血流动力学监测,机械通气和肾脏替代治疗。如果第7天的SOFA评分显示临床恶化且没有可用的治疗选择,则应召开一次跨学科会议,包括一项道德咨询,以做出生命周期决定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号